262 related articles for article (PubMed ID: 31668806)
21. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
Wang F; Ruan L; Yang J; Zhao Q; Wei W
Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
[TBL] [Abstract][Full Text] [Related]
22. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
24. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
[TBL] [Abstract][Full Text] [Related]
25. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
26. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
27. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
Yin H; Li Z; Chen J; Hu X
J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
[TBL] [Abstract][Full Text] [Related]
29. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
[TBL] [Abstract][Full Text] [Related]
30. TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1/STAT3 pathway.
Jin Z; Li H; Hong X; Ying G; Lu X; Zhuang L; Wu S
Cancer Cell Int; 2018; 18():202. PubMed ID: 30555277
[TBL] [Abstract][Full Text] [Related]
31. Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases.
Hwang ES; Kim DW; Hwang JH; Jung HS; Suh JM; Park YJ; Chung HK; Song JH; Park KC; Park SH; Yun HJ; Kim JM; Shong M
Mol Endocrinol; 2004 Nov; 18(11):2672-84. PubMed ID: 15297606
[TBL] [Abstract][Full Text] [Related]
32. TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer.
Hai J; Zhu CQ; Wang T; Organ SL; Shepherd FA; Tsao MS
Sci Rep; 2017 Jan; 7():39692. PubMed ID: 28059079
[TBL] [Abstract][Full Text] [Related]
33. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
34. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.
Xu J; Cai J; Jin X; Yang J; Shen Q; Ding X; Liang Y
Oncol Rep; 2015 Sep; 34(3):1424-30. PubMed ID: 26133772
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory roles of miR‑9 on papillary thyroid cancer through targeting BRAF.
Gu Y; Yang N; Yin L; Feng C; Liu T
Mol Med Rep; 2018 Jul; 18(1):965-972. PubMed ID: 29767243
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].
Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987
[TBL] [Abstract][Full Text] [Related]
38. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
[TBL] [Abstract][Full Text] [Related]
39. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
[TBL] [Abstract][Full Text] [Related]
40. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
Wang R; Zhao L; Ji L; Bai L; Wen Q
Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]